Impact of Body Composition on Clinical Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Plus Chemotherapy
Annali Italiani di Chirurgia · 20.06.2024 · 95 (3)
DOI: 10.62713/aic.3336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annali Italiani di Chirurgia, online erschienen am 20.06.2024. Verfasst von Yuan Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital, Anhui Medical University, 230022 Hefei, Anhui, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Esophageal Neoplasms, Body Composition, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
AIM: Some studies have reported that body composition profiles affect clinical outcomes of multidisciplinary treatments in several types of cancers; however, a paucity of data exists on the association in neoadjuvant immunotherapy. In the present study, we aimed to investigate the effect of body composition on the clinical outcomes of patients with esophageal squamous cell carcinoma (ESCC) receiving neoadjuvant immunotherapy plus chemotherapy (nICT). METHODS: Clinicopathological data and computed tomography (CT) images of 85 patients with locally advanced ESCC who underwent esophagectomy after nICT were collected. At diagnosis and before surgery, the CT scan of the third lumbar vertebra was chosen to evaluate the skeletal muscle index (SMI), skeletal muscle radiodensity (SMD), the subcutaneous and the visceral adiposity index. The relationships between body composition and tumor response after nICT and postoperative complications were analyzed. RESULTS: The clinical stage (Odds Ratio (OR) 0.345, 95% confidence interval (CI) 0.141–0.844, p = 0.020) and change in SMI (∆SMI, OR 1.394, 95% CI 1.061–1.832, p = 0.017) were associated with tumor remission after nICT. Moreover, the multivariate logistic analysis revealed that ∆SMI (OR 0.598, 95% CI 0.433–0.828, p = 0.002) was associated with the incidence of postoperative complications. Patients with ∆SMI
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital, Anhui Medical University, 230022 Hefei, Anhui, China.
- The First Clinical Medical College, Anhui Medical University, 230032 Hefei, Anhui, China.
- The Second Clinical Medical College, Anhui Medical University, 230032 Hefei, Anhui, China.
- Department of Radiology, The First Affiliated Hospital, Anhui Medical University, 230022 Hefei, Anhui, China.
Zitieren
APA
Zhao, Y., Xia, M., Dang, Y., Li, Y., Zhao, X., Kang, N., Zuo, J., & Zhang, R. (2024). Impact of Body Composition on Clinical Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Plus Chemotherapy. Annali Italiani di Chirurgia, 95(3). https://doi.org/10.62713/aic.3336
Vancouver
Zhao Y, Xia M, Dang Y, Li Y, Zhao X, Kang N, et al. Impact of Body Composition on Clinical Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Plus Chemotherapy. Annali Italiani di Chirurgia. 2024;95(3). doi:10.62713/aic.3336
BibTeX
@article{Zhao2024,
author = {Zhao, Yuan and Xia, Mingxin and Dang, Yan and Li, Yifan and Zhao, Xiaoying and Kang, Ningning and Zuo, Jianhui and Zhang, Renquan},
title = {Impact of Body Composition on Clinical Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Plus Chemotherapy},
journal = {Annali Italiani di Chirurgia},
year = {2024},
volume = {95},
number = {3},
doi = {10.62713/aic.3336}
}
EUVIMED